Shares fall as drugmakers drop amid corruption probe
China’s stocks fell on Thursday, dragging the benchmark index down the most in two weeks, as drugmakers slid amid the start of a corruption probe and automakers declined. Jiangsu Hengrui Medicine Co and Beijing SL Pharmaceutical Co sank more than 5 percent. Regulators will crack down on illegal competition and bribery in drug sales and medical services. The Shanghai Composite Index lost 0.9 percent to 2,081.88 at the close. The index has climbed 6.8 percent since reaching a more than four-year low on June 27 as July data from exports to industrial output improved.